We revealed that spironolactone suppressed the expression of survivin, an anti-apoptotic protein, at a concentration that was harmless to non-cancer cells and also chemosensitized cancer cells and CSCs to anticancer reagents, such as gemcitabine and osimertinib. Here, BIRC5 is linked to cancer.